Successful Dartmouth TB Vaccine Moves Forward After Phase 2 Trial
Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine from a three-year trial in Tanzania were announced by investigators at Dartmouth’s Geisel School of Medicine and published in the journal Vaccine.
Source: News at Dartmouth Medical School - Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release Research Tanzania tubercolosis Source Type: news
More News: Hospital Management | Tanzania Health | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines